Literature DB >> 17767916

Influenza A virus non-structural protein 1 (NS1) interacts with cellular multifunctional protein nucleolin during infection.

Rikinori Murayama1, Yuichi Harada, Toshikatsu Shibata, Kazumichi Kuroda, Satoshi Hayakawa, Kazufumi Shimizu, Torahiko Tanaka.   

Abstract

Influenza A virus non-structural protein 1 (NS1) is the most important viral regulatory factor that controls cellular processes to facilitate viral replication. To gain further insight into the role of NS1, we tried to find novel cellular factors that interact with NS1. The complexes of NS1 and target proteins were pulled down from an infected cell lysate using anti-NS1 (A/Udorn/72) single-chain Fv and identified by peptide mass fingerprinting analysis. We identified nucleolin, a multifunctional major nucleolar protein, as a novel NS1-binding protein. The RNA-binding domain of NS1 was responsible for this binding, as judged by a GST (glutathione S-transferase) pull-down assay with the GST-fused functional domains of NS1. By laser confocal microscopy, we observed the co-localization of NS1 with nucleolin most clearly in the nucleoli, indicating that NS1 is interacting with nucleolin during infection. Our results suggest a novel function of NS1, namely, affecting cellular events via interaction with nucleolin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17767916     DOI: 10.1016/j.bbrc.2007.08.091

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  24 in total

1.  Intracellular distribution of NS1 correlates with the infectivity and interferon antagonism of an avian influenza virus (H7N1).

Authors:  Bjoern Keiner; Benjamin Maenz; Ralf Wagner; Giovanni Cattoli; Ilaria Capua; Hans-Dieter Klenk
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

Review 2.  Understanding the focused CD4 T cell response to antigen and pathogenic organisms.

Authors:  Jason M Weaver; Andrea J Sant
Journal:  Immunol Res       Date:  2009-02-07       Impact factor: 2.829

3.  The R35 residue of the influenza A virus NS1 protein has minimal effects on nuclear localization but alters virus replication through disrupting protein dimerization.

Authors:  Erin N Lalime; Andrew Pekosz
Journal:  Virology       Date:  2014-05-05       Impact factor: 3.616

4.  Antiviral Action of Methylated β-Lactoglobulin on the Human Influenza Virus A Subtype H3N2.

Authors:  Mahmoud Sitohy; Bernard Besse; Sylviane Billaudel; Thomas Haertlé; Jean-Marc Chobert
Journal:  Probiotics Antimicrob Proteins       Date:  2010-06       Impact factor: 4.609

Review 5.  The influenza virus NS1 protein as a therapeutic target.

Authors:  Daniel A Engel
Journal:  Antiviral Res       Date:  2013-06-21       Impact factor: 5.970

6.  Differential effects of NS1 proteins of human pandemic H1N1/2009, avian highly pathogenic H5N1, and low pathogenic H5N2 influenza A viruses on cellular pre-mRNA polyadenylation and mRNA translation.

Authors:  Denis E Kainov; Konstantin H Müller; Linda L Theisen; Maria Anastasina; Minttu Kaloinen; Claude P Muller
Journal:  J Biol Chem       Date:  2010-12-16       Impact factor: 5.157

7.  Interaction of influenza virus NS1 protein with growth arrest-specific protein 8.

Authors:  Lixia Zhao; Long Xu; Xiaowei Zhou; Qingyu Zhu; Zhixin Yang; Chuanfu Zhang; Xudong Zhu; Mengbin Yu; Yingying Zhang; Xinghui Zhao; Peitang Huang
Journal:  Virol J       Date:  2009-12-09       Impact factor: 4.099

8.  Nucleolin/Nsr1p binds to the 3' noncoding region of the tombusvirus RNA and inhibits replication.

Authors:  Yi Jiang; Zhenghe Li; Peter D Nagy
Journal:  Virology       Date:  2009-10-27       Impact factor: 3.616

9.  HLA class I molecules reflect an altered host proteome after influenza virus infection.

Authors:  Angela Wahl; Fredda Schafer; Wilfried Bardet; William H Hildebrand
Journal:  Hum Immunol       Date:  2010-01       Impact factor: 2.850

10.  Influenza A H3N2 subtype virus NS1 protein targets into the nucleus and binds primarily via its C-terminal NLS2/NoLS to nucleolin and fibrillarin.

Authors:  Krister Melén; Janne Tynell; Riku Fagerlund; Pascal Roussel; Danièle Hernandez-Verdun; Ilkka Julkunen
Journal:  Virol J       Date:  2012-08-21       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.